ABBV AbbVie Inc. Loading...

Loading chart...
Top Calls

No data yet

Price change since each call, adjusted for long/short direction. Results calculated:

Feed
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
0 selected
All Content✓
Source feeds
Buzzberg Top 50 ✓
All market capsNo capitalization filter✓
200 B and aboveMega✓
10 B to 200 BLarge✓
2 B to 10 BMid✓
0 to 2 BSmall✓
Custom
Enter market cap range in B USD
Time Author Thesis Company / ticker Signal Since call Position Source
17:16
Oct 06
Nancy Tengler Bloomberg Markets
Bloomberg Markets
Healthcare AI drug discovery beneficiaries
Healthcare companies will be beneficiaries of the AI buildout through drug discovery; she added to high-quality laggards J&J, AbbVie and Lilly, where earnings growth remains robust.
ABBV AbbVie Inc. Long 1ST Position: Added —
16:37
Aug 10
asklivermore
Long AbbVie, healthcare winner up 17% Portfolio
Author discloses an ongoing long position in AbbVie within a healthcare/biotech sleeve; currently up 17%+ and held as a core winner in the portfolio.
ABBV AbbVie Inc. Long — —
15:42
Aug 09
BarbarianCap
Lupron demand seen lifted by fertility spotlight
Buy ABBV as Lupron, used in fertility protocols, stands to benefit from increased public attention on fertility treatments driven by AOC's egg-freezing news; very thin catalyst.
ABBV AbbVie Inc. Long 1ST — —
Log in to see ideas

About ABBV Investor Commentary

Across the available history and selected sources, Buzzberg tracks ABBV (AbbVie Inc.) across 23 sources: 16 bullish vs 0 bearish calls from 28 authors. Historical directional balance: 16% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 99 total trade ideas tracked. Past 7 days, before deduplication: 3 other directions. Latest voices: Nancy Tengler, asklivermore, BarbarianCap.